Therefore, it is worth exploring whether the effect of SGLT2 inhibitors on blood lipid levels in type 2 diabetes mellitus patients is related to the dosages of SGLT2 inhibitors and the degree of correlation. The gene discussed is SLC5A2; the disease is diabetes mellitus.